九洲药业(603456.SH)：子公司拟出资1000万元参与投资嘉兴隆峰创业投资合伙企业

Core Viewpoint - Jiuzhou Pharmaceutical (603456.SH) announced its subsidiary Hongzhou Investment's participation in a partnership to invest in Jiaxing Longfeng Venture Capital Partnership, focusing on the pharmaceutical sector, particularly in new drug and medical device development [1] Investment Details - The total committed capital for the partnership is RMB 77 million, with Hongzhou Investment contributing RMB 10 million, representing 12.987% of the total [1] - The investment will primarily target high-quality emerging medical enterprises, including but not limited to new drugs, innovative drugs, medical devices, medical services, diagnostics, biotechnology, and pharmaceutical outsourcing research and development [1]